Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Xcellerant Ventures is a venture capital firm founded by John Shufeldt, Douglas Sylvester, and Chris Yoo. Established to invest in technologies that enhance healthcare, the firm leverages over seven decades of combined experience in medical technologies, law, and entrepreneurship. The firm is headquartered in the United States and focuses on early-stage investments in the healthcare sector.
Currently, Xcellerant Ventures manages a portfolio of three notable companies, emphasizing their commitment to supporting innovative solutions in healthtech and medtech. The firm aims to improve the quality, efficiency, access, and delivery of healthcare while reducing costs. Their approach is rooted in a deep understanding of the healthcare landscape and a desire to address real-world challenges.
Xcellerant Ventures specializes in early-stage funding for healthtech and medtech companies. Their investment strategy prioritizes dynamic founders and companies with rapid exit potential. The firm is particularly interested in businesses that have cleared regulatory hurdles and demonstrate a clear path to financial growth.
Investment stages include pre-seed, seed, seed-plus (extension), and Series A. Xcellerant Ventures seeks to partner with companies that are poised for significant impact in the healthcare sector, focusing on those that address pressing healthcare challenges through innovative technologies.
Xcellerant Ventures has a focused portfolio that includes three notable companies:
These companies exemplify Xcellerant's commitment to investing in transformative healthtech and medtech solutions.
John Shufeldt - General Partner: John has extensive experience in medical technologies and law, contributing to the firm's strategic direction.
Douglas Sylvester - General Partner: Douglas brings a wealth of knowledge in entrepreneurship and healthcare investments.
Chris Yoo - General Partner: Chris has a strong background in law and healthcare, enhancing the firm's investment strategy.
Michael Shufeldt - General Partner: Michael's expertise in medical technologies supports the firm's focus on innovative healthcare solutions.
TJ Kline, James Mago, Tiffany Youtchoko, Yvette Ferreira, Amanda Best, Dave Pulver, Anne Mazet, Haley Ha: These team members contribute diverse skills and experiences, enhancing the firm's operational capabilities.
Founders can pitch Xcellerant Ventures through their website's contact form. It is essential to include a detailed business plan and any relevant financial projections.
Recently, Xcellerant Ventures has published blog posts discussing the democratization of healthcare through technology and the operational expansion of their portfolio company, Nanodropper, now known as Mu Medical. These posts reflect the firm's ongoing engagement with industry trends and developments.
What are Xcellerant Ventures' investment criteria?
Xcellerant Ventures focuses on early-stage healthtech and medtech companies that have cleared regulatory hurdles and demonstrate a clear path to financial growth. They prioritize dynamic founders and companies with rapid exit potential.
How can I pitch to Xcellerant Ventures?
Founders can submit their pitch through the contact form available on the Xcellerant Ventures website. It is recommended to include a clear business model, market analysis, and details on regulatory status.
What stages does Xcellerant Ventures invest in?
The firm invests in pre-seed, seed, seed-plus (extension), and Series A stages, focusing on early-stage companies in the healthcare sector.
What makes Xcellerant Ventures different from other investors?
Xcellerant Ventures emphasizes a deep understanding of healthcare challenges and invests in companies that are positioned to make a significant impact. Their founding team has extensive experience in medical technologies and law, providing valuable insights to portfolio companies.
What is the typical check size for investments?
While specific check sizes are not disclosed, Xcellerant Ventures focuses on early-stage funding, which typically ranges from pre-seed to Series A investments.
What kind of support do portfolio companies receive?
Portfolio companies benefit from the extensive experience of the Xcellerant team, including mentorship, operational support, and access to a network of industry contacts.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.